Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism-Reference-Cited by-同舟云学术

Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism

Published:2001-08 Issue:8 Volume:133 Page:1355-1361
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Vargas M Luisa,Abella Cristina,Hernandez Jesus

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704201/fullpdf

Reference41 articles.

1. Adenosine regulates the release of adrenocorticotropic hormone (ACTH) from cultured anterior pituitary cells;ANAND-SRIVASTAVA;Mol. Cell. Biochem.,1989

2. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone;ASABA;Brain Res.,1998

3. A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential target for antidepressant drugs;BORGER;Mol. Cell. Biol.,1993

4. Flumazenil. A reappraisal of its pharmacological properties and therapeutics efficacy as a benzodiazepine antagonist;BROGDEN;Drugs,1991

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Functions of the Hypothalamus: Linking Cognition, Emotion and Physiology for Well-being and Adaptability;Annals of Neurosciences;2024-06-12

2. Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport;Journal of Ethnopharmacology;2024-04

3. Tribuloside Acts on the Pde/Camp/Pka Pathway to Enhance Melanogenesis, Melanocyte Dendricity and Melanosome Transport;2023

4. Diazepam enhances melanogenesis, melanocyte dendricity and melanosome transport via the PBR/cAMP/PKA pathway;The International Journal of Biochemistry & Cell Biology;2019-11

5. Diazepam is not a direct allosteric modulator of α 1 ‐adrenoceptors, but modulates receptor signaling by inhibiting phosphodiesterase‐4;Pharmacology Research & Perspectives;2018-12-26